Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
| Molecular Weight | 136.11 g/mol |
|---|---|
| Molecular Formula | C5H4N4O |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 136.03851076 g/mol |
| Monoisotopic Mass | 136.03851076 g/mol |
| Topological Polar Surface Area | 65.8 A^2 |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 275 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 10 | |
|---|---|
| Drug Name | Allopurinol |
| PubMed Health | Allopurinol |
| Drug Classes | Antigout, Urinary Stone Agent |
| Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
| Active Ingredient | Allopurinol |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 300mg; 100mg |
| Market Status | Prescription |
| Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
| 2 of 10 | |
|---|---|
| Drug Name | Allopurinol sodium |
| PubMed Health | Allopurinol (Injection) |
| Drug Classes | Antigout, Urinary Stone Agent |
| Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Eurohlth Intl |
| 3 of 10 | |
|---|---|
| Drug Name | Aloprim |
| PubMed Health | Allopurinol |
| Drug Classes | Antigout, Urinary Stone Agent |
| Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Mylan Institutional |
| 4 of 10 | |
|---|---|
| Drug Name | Lopurin |
| Active Ingredient | Allopurinol |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 300mg; 100mg |
| Market Status | Prescription |
| Company | Dr Reddys La |
| 5 of 10 | |
|---|---|
| Drug Name | Zyloprim |
| Active Ingredient | Allopurinol |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 300mg; 100mg |
| Market Status | Prescription |
| Company | Prometheus Labs |
| 6 of 10 | |
|---|---|
| Drug Name | Allopurinol |
| PubMed Health | Allopurinol |
| Drug Classes | Antigout, Urinary Stone Agent |
| Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
| Active Ingredient | Allopurinol |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 300mg; 100mg |
| Market Status | Prescription |
| Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
| 7 of 10 | |
|---|---|
| Drug Name | Allopurinol sodium |
| PubMed Health | Allopurinol (Injection) |
| Drug Classes | Antigout, Urinary Stone Agent |
| Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Eurohlth Intl |
| 8 of 10 | |
|---|---|
| Drug Name | Aloprim |
| PubMed Health | Allopurinol |
| Drug Classes | Antigout, Urinary Stone Agent |
| Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
| Active Ingredient | Allopurinol sodium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 500mg base/vial |
| Market Status | Prescription |
| Company | Mylan Institutional |
| 9 of 10 | |
|---|---|
| Drug Name | Lopurin |
| Active Ingredient | Allopurinol |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 300mg; 100mg |
| Market Status | Prescription |
| Company | Dr Reddys La |
| 10 of 10 | |
|---|---|
| Drug Name | Zyloprim |
| Active Ingredient | Allopurinol |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 300mg; 100mg |
| Market Status | Prescription |
| Company | Prometheus Labs |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37104
Submission : 2023-01-20
Status : Active
Type : II
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39568
Submission : 2024-03-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4307
Submission : 1981-10-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4950
Submission : 1983-02-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5235
Submission : 1984-01-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3480
Submission : 1979-03-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2870
Submission : 1977-02-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2506
Submission : 1975-08-13
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3583
Submission : 1979-07-22
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2534
Submission : 1975-10-13
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 100MG
USFDA APPLICATION NUMBER - 16084
DOSAGE - TABLET;ORAL - 200MG
USFDA APPLICATION NUMBER - 16084
DOSAGE - TABLET;ORAL - 300MG
USFDA APPLICATION NUMBER - 16084
DOSAGE - TABLET;ORAL - 200MG;200MG
USFDA APPLICATION NUMBER - 209203
DOSAGE - TABLET;ORAL - 300MG;200MG
USFDA APPLICATION NUMBER - 209203
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ashland
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Coating Systems & Additives
Disintegrants & Superdisintegrants
Direct Compression
Granulation
Thickeners and Stabilizers
Controlled & Modified Release
Lubricants & Glidants
Co-Processed Excipients
Solubilizers
Chewable & Orodispersible Aids
Film Formers & Plasticizers
Taste Masking
Rheology Modifiers
Empty Capsules
API Stability Enhancers
Emulsifying Agents
Vegetarian Capsules
Coloring Agents
Topical
Parenteral
Surfactant & Foaming Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
10
PharmaCompass offers a list of Allopurinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Allopurinol manufacturer or Allopurinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Allopurinol manufacturer or Allopurinol supplier.
PharmaCompass also assists you with knowing the Allopurinol API Price utilized in the formulation of products. Allopurinol API Price is not always fixed or binding as the Allopurinol Price is obtained through a variety of data sources. The Allopurinol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one, including repackagers and relabelers. The FDA regulates 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one supplier is an individual or a company that provides 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one active pharmaceutical ingredient (API) or 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one finished formulations upon request. The 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers may include 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one API manufacturers, exporters, distributors and traders.
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one DMF (Drug Master File) is a document detailing the whole manufacturing process of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one active pharmaceutical ingredient (API) in detail. Different forms of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one DMFs exist exist since differing nations have different regulations, such as 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one DMF submitted to regulatory agencies in the US is known as a USDMF. 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one USDMF includes data on 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one Drug Master File in Japan (1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one JDMF) empowers 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one JDMF during the approval evaluation for pharmaceutical products. At the time of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one Drug Master File in Korea (1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one. The MFDS reviews the 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one KDMF as part of the drug registration process and uses the information provided in the 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one KDMF to evaluate the safety and efficacy of the drug.
After submitting a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers with KDMF on PharmaCompass.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEP of the European Pharmacopoeia monograph is often referred to as a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one Certificate of Suitability (COS). The purpose of a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one to their clients by showing that a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEP has been issued for it. The manufacturer submits a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEP holder for the record. Additionally, the data presented in the 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one DMF.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers with CEP (COS) on PharmaCompass.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one written confirmation (1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one WC) is an official document issued by a regulatory agency to a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one manufacturer, verifying that the manufacturing facility of a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one APIs or 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one finished pharmaceutical products to another nation, regulatory agencies frequently require a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one WC (written confirmation) as part of the regulatory process.
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one suppliers with NDC on PharmaCompass.
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one GMP manufacturer or 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one GMP API supplier for your needs.
A 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CoA (Certificate of Analysis) is a formal document that attests to 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one's compliance with 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one specifications and serves as a tool for batch-level quality control.
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CoA mostly includes findings from lab analyses of a specific batch. For each 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one may be tested according to a variety of international standards, such as European Pharmacopoeia (1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one EP), 1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one USP).
